Addressing Dementia Via Agitation-Centered Evaluation
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Addressing Dementia Via Agitation-Centered Evaluation is a clinical trial[1].
Key Facts
- Addressing Dementia Via Agitation-Centered Evaluation is in the country of Australia[2].
- Addressing Dementia Via Agitation-Centered Evaluation is in the country of United States[3].
- Addressing Dementia Via Agitation-Centered Evaluation's instance of is recorded as clinical trial[4].
- Addressing Dementia Via Agitation-Centered Evaluation's start time is recorded as +2017-07-13T00:00:00Z[5].
- Addressing Dementia Via Agitation-Centered Evaluation's end time is recorded as +2019-08-31T00:00:00Z[6].
- Addressing Dementia Via Agitation-Centered Evaluation's main subject is recorded as dementia[7].
- Addressing Dementia Via Agitation-Centered Evaluation's main subject is recorded as psychomotor agitation[8].
- Addressing Dementia Via Agitation-Centered Evaluation's number of participants is recorded as {'unit': '1', 'amount': '+435'}[9].
- Addressing Dementia Via Agitation-Centered Evaluation's title is recorded as A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's Type[10].
- Addressing Dementia Via Agitation-Centered Evaluation's short name is recorded as ADVANCE[11].
- Addressing Dementia Via Agitation-Centered Evaluation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[12].
- Addressing Dementia Via Agitation-Centered Evaluation's ClinicalTrials.gov ID is recorded as NCT03226522[13].
- Addressing Dementia Via Agitation-Centered Evaluation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+90'}[14].
- Addressing Dementia Via Agitation-Centered Evaluation's research intervention is recorded as bupropion[15].
- Addressing Dementia Via Agitation-Centered Evaluation's clinical trial phase is recorded as phase II clinical trial[16].
- Addressing Dementia Via Agitation-Centered Evaluation's clinical trial phase is recorded as phase III clinical trial[17].
- Addressing Dementia Via Agitation-Centered Evaluation's research subject recruitment status is recorded as recruiting[18].
- Addressing Dementia Via Agitation-Centered Evaluation's study type is recorded as interventional study[19].